Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Celltrion Inc

+ Add to Watchlist

068270:KS

62,300 KRW 00.00%

As of 01:29:08 ET on 03/02/2015.

Snapshot for Celltrion Inc (068270)

Open: - Day's Range: - Volume: 2,808,599
Previous Close: 62,300 52wk Range: 35,476 - 75,700 1-Yr Rtn: +32.02%

Stock Chart for 068270

No chart data available.
  • 068270:KS 62,300
  • 1D
  • 1M
  • 1Y
62,300
Interactive 068270 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 068270

Current P/E Ratio (ttm) 67.0923
Estimated P/E(12/2015) -
Relative P/E vs. KOSPI 2.2625
Earnings Per Share (KRW) (ttm) 928.5714
Est. EPS (KRW) (12/2015) -
Est. PEG Ratio -
Market Cap (M KRW) 6,452,493.92
Shares Outstanding (M) 103.57
30 Day Average Volume 2,561,619
Price/Book (mrq) 5.4347
Price/Sale (ttm) 17.6763
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 068270

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 068270

Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment.

Seo Jung-JinChairman/CEO/Rep DirectorPark Seong-DoVice Chairman
Hong Seung-SeoPresidentKim Gwang-HoPresident
More Company Profile & Key Executives for 068270

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil